These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
226 related items for PubMed ID: 29642855
1. MiR-30a-5p confers cisplatin resistance by regulating IGF1R expression in melanoma cells. Li Y, Zhang J, Liu Y, Zhang B, Zhong F, Wang S, Fang Z. BMC Cancer; 2018 Apr 11; 18(1):404. PubMed ID: 29642855 [Abstract] [Full Text] [Related]
2. miR-1271 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R, IRS1, mTOR, and BCL2. Yang M, Shan X, Zhou X, Qiu T, Zhu W, Ding Y, Shu Y, Liu P. Anticancer Agents Med Chem; 2014 Apr 11; 14(6):884-91. PubMed ID: 24875127 [Abstract] [Full Text] [Related]
3. DDP-resistant ovarian cancer cells-derived exosomal microRNA-30a-5p reduces the resistance of ovarian cancer cells to DDP. Liu R, Zhang Y, Sun P, Wang C. Open Biol; 2020 Apr 11; 10(4):190173. PubMed ID: 32343928 [Abstract] [Full Text] [Related]
4. MicroRNA-139-5p modulates the growth and metastasis of malignant melanoma cells via the PI3K/AKT signaling pathway by binding to IGF1R. Yang C, Xia Z, Zhu L, Li Y, Zheng Z, Liang J, Wu L. Cell Cycle; 2019 Dec 11; 18(24):3513-3524. PubMed ID: 31724454 [Abstract] [Full Text] [Related]
5. Exosome-Derived Circ-PVT1 Contributes to Cisplatin Resistance by Regulating Autophagy, Invasion, and Apoptosis Via miR-30a-5p/YAP1 Axis in Gastric Cancer Cells. Yao W, Guo P, Mu Q, Wang Y. Cancer Biother Radiopharm; 2021 May 11; 36(4):347-359. PubMed ID: 32799541 [Abstract] [Full Text] [Related]
7. A Feedback Loop Between miR-30a/c-5p and DNMT1 Mediates Cisplatin Resistance in Ovarian Cancer Cells. Han X, Zhen S, Ye Z, Lu J, Wang L, Li P, Li J, Zheng X, Li H, Chen W, Li X, Zhao L. Cell Physiol Biochem; 2017 May 11; 41(3):973-986. PubMed ID: 28222434 [Abstract] [Full Text] [Related]
9. MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer. Li M, Chen W, Zhang H, Zhang Y, Ke F, Wu X, Zhang Y, Weng M, Liu Y, Gong W. Oncotarget; 2016 Dec 13; 7(50):83060-83070. PubMed ID: 27825112 [Abstract] [Full Text] [Related]
10. MiR-223 promotes the cisplatin resistance of human gastric cancer cells via regulating cell cycle by targeting FBXW7. Zhou X, Jin W, Jia H, Yan J, Zhang G. J Exp Clin Cancer Res; 2015 Mar 26; 34(1):28. PubMed ID: 25888377 [Abstract] [Full Text] [Related]
11. Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Qin X, Yu S, Zhou L, Shi M, Hu Y, Xu X, Shen B, Liu S, Yan D, Feng J. Int J Nanomedicine; 2017 Mar 26; 12():3721-3733. PubMed ID: 28553110 [Abstract] [Full Text] [Related]
12. MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells. Jiang L, Liu X, Chen Z, Jin Y, Heidbreder CE, Kolokythas A, Wang A, Dai Y, Zhou X. Biochem J; 2010 Nov 15; 432(1):199-205. PubMed ID: 20819078 [Abstract] [Full Text] [Related]
14. Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner. Wang B, Zhang Y, Ye M, Wu J, Ma L, Chen H. Curr Drug Metab; 2019 Nov 15; 20(10):804-814. PubMed ID: 31424364 [Abstract] [Full Text] [Related]
17. TRIM8 restores p53 tumour suppressor function by blunting N-MYC activity in chemo-resistant tumours. Mastropasqua F, Marzano F, Valletti A, Aiello I, Di Tullio G, Morgano A, Liuni S, Ranieri E, Guerrini L, Gasparre G, Sbisà E, Pesole G, Moschetta A, Caratozzolo MF, Tullo A. Mol Cancer; 2017 Mar 21; 16(1):67. PubMed ID: 28327152 [Abstract] [Full Text] [Related]
18. MicroRNA-30a Inhibits Colorectal Cancer Metastasis Through Down-Regulation of Type I Insulin-Like Growth Factor Receptor. Liu YC, Park YR, Kim SL, Lee ST, Kim SW. Dig Dis Sci; 2017 Nov 21; 62(11):3040-3049. PubMed ID: 28932920 [Abstract] [Full Text] [Related]
20. MiR-30a-5p Enhances Cisplatin Sensitivity by Downregulating RIF1 in Ovarian Cancer. Yao W, Wang Y, Huang M, Zhou J, Zheng R, Jin C, Zhang Y. Ann Clin Lab Sci; 2023 May 21; 53(3):418-426. PubMed ID: 37437929 [Abstract] [Full Text] [Related] Page: [Next] [New Search]